|
2025
|
Invention
|
Aryl ether-substituted heterocyclic compounds as glp1r agonists.
The present invention relates t... |
|
|
Invention
|
Aryl ether-substituted heterocyclic compounds as glp1r agonists.
A novel aryl ether substituted ... |
|
2024
|
Invention
|
Novel fused heterocyclic compound serving as cdk inhibitor and use thereof. Disclosed in the pres... |
|
|
Invention
|
New substituted heterocyclic compound as gspts/myc signal flux regulator. Disclosed in the presen... |
|
|
Invention
|
Pyrimido macroheterocyclic compound as wee1-yes dual-target inhibitor and use thereof. Disclosed ... |
|
|
Invention
|
New fused heterocyclic compound as cdks inhibitor and use thereof. Disclosed in the present inven... |
|
|
Invention
|
Method for manufacturing glp-1r agonist, intermediate, and use thereof. The present invention rel... |
|
2023
|
Invention
|
Novel heterocyclic compound acting as cdks inhibitor, and use thereof. Disclosed is a novel heter... |
|
|
Invention
|
Polymorph of glp-1r agonist compound, preparation method therefor, and use thereof. Provided are ... |
|
|
Invention
|
Novel aryl deuterated benzyl ether substituted heterocyclic compound as glp1r agonist. The presen... |
|
|
Invention
|
Salt of glp-1r agonist, preparation method therefor and use thereof. The present invention relate... |
|
|
Invention
|
Novel pyrimidine or triazine-substituted pyridoheterocyclic compound. Disclosed is a novel substi... |
|
|
Invention
|
New fused-heterocyclic compound as cdk inhibitor and use thereof. Disclosed in the present invent... |
|
|
Invention
|
Novel pyrimido-heterocyclic novel compound serving as wee1 inhibitor and application thereof. Dis... |
|
|
Invention
|
Novel substituted macroheterocyclic compounds and use thereof. Disclosed in the present invention... |
|
2022
|
Invention
|
Novel pyrido or triazine-substituted pyrido heterocyclic compound. A substituted pyrido heterocyc... |
|
|
Invention
|
Aryl-substituted heterocyclic compound. Disclosed is a novel substituted heterocyclic compound, w... |
|
|
Invention
|
Novel aryl ether substituted heterocyclic compound as glp1r agonist. The present invention relate... |
